ストックスクリーナーアプリを入手
38.50
0.92%
0.35
アフターアワーズ：
38.50
前日終値:
$38.15
開ける：
$38.13
24時間の取引高:
486.05K
Relative Volume:
0.60
時価総額：
$2.24B
収益：
$899.11M
当期純損益:
$145.62M
株価収益率:
15.51
EPS:
2.4829
ネットキャッシュフロー:
$322.54M
1週間 パフォーマンス:
+0.94%
1か月 パフォーマンス:
+9.00%
6か月 パフォーマンス:
+36.57%
1年 パフォーマンス:
+1.69%
1日の値動き範囲:
$37.48
$38.93
1週間の範囲:
$37.48
$40.02
52週間の値動き範囲:
$25.52
$40.87
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
名前
Harmony Biosciences Holdings Inc
セクター
電話
(484) 539-9800
住所
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Compare HRMY vs VRTX, REGN, ARGX, MRNA, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
38.50 | 2.22B | 899.11M | 145.62M | 322.54M | 2.4829 |
VRTX
Vertex Pharmaceuticals Inc
|
547.59 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
828.50 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,011.11 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
138.89 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
211.58 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-23 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2026-02-23 | ダウングレード | Truist | Buy → Hold |
| 2026-02-11 | 再開されました | UBS | Neutral |
| 2025-07-21 | 開始されました | Truist | Buy |
| 2025-07-10 | 再開されました | Goldman | Neutral |
| 2025-06-02 | 再開されました | Oppenheimer | Outperform |
| 2025-02-11 | 開始されました | Deutsche Bank | Buy |
| 2024-12-17 | 開始されました | H.C. Wainwright | Buy |
| 2024-10-10 | 再開されました | Raymond James | Outperform |
| 2024-09-10 | 開始されました | UBS | Buy |
| 2024-06-21 | 開始されました | Citigroup | Buy |
| 2024-01-02 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-09-25 | ダウングレード | Goldman | Neutral → Sell |
| 2023-09-07 | 開始されました | Berenberg | Buy |
| 2023-04-20 | 開始されました | BofA Securities | Neutral |
| 2022-10-14 | アップグレード | Janney | Neutral → Buy |
| 2022-10-14 | アップグレード | Jefferies | Hold → Buy |
| 2022-08-03 | ダウングレード | Jefferies | Buy → Hold |
| 2022-07-13 | ダウングレード | Goldman | Buy → Neutral |
| 2022-07-07 | 開始されました | Mizuho | Buy |
| 2022-04-14 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-12-01 | 開始されました | Oppenheimer | Outperform |
| 2021-11-04 | 開始されました | Raymond James | Outperform |
| 2021-09-23 | 開始されました | Needham | Buy |
| 2021-03-29 | アップグレード | Goldman | Neutral → Buy |
| 2020-09-14 | 開始されました | Goldman | Neutral |
| 2020-09-14 | 開始されました | Jefferies | Buy |
| 2020-09-14 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Harmony Biosciences Holdings Inc (HRMY) 最新ニュース
Virtus Advisers LLC Makes New Investment in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Tieton Capital Management LLC Takes Position in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Denali Advisors LLC Purchases 29,700 Shares of Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Stephen M. Mollichella Net Worth (2026) - GuruFocus
Aurora Investment Counsel Invests $2.37 Million in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Did Strong Q2 Earnings and Completed Buybacks Just Shift Harmony Biosciences' (HRMY) Investment Narrative? - simplywall.st
Chase Investment Counsel Corp Takes $1.82 Million Position in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences (NASDAQ:HRMY) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat
HRMY Stock On Track For Best Intraday Gains In 18 Months — What Did Mizuho Analysts Say? - stocktwits.com
Harmony Biosciences Highlights Record WAKIX Growth, Advances Orexin and Epilepsy Pipeline - MarketBeat
HRMY: Record WAKIX sales drive CNS pipeline progress, with BP-205 and new pitolisant forms advancing - TradingView
Analysts Are Bullish on Top Healthcare Stocks: Aura Biosciences Inc (AURA), Corbus Pharmaceuticals (CRBP) - The Globe and Mail
Zacks Research Downgrades Harmony Biosciences (NASDAQ:HRMY) to Hold - MarketBeat
Harmony Biosciences Holdings, I (HRMY) Stock Forecasts - Yahoo Finance
Harmony Sets Investor Appearance as CNS Strategy Advances - MyChesCo
Hennion & Walsh Asset Management Inc. Decreases Stock Holdings in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences Holdings (HRMY) Stock Analysis: Exploring an 18% Potential Upside with Strong Revenue Growth - DirectorsTalk Interviews
Harmony Biosciences Holdings, Inc. $HRMY Shares Sold by Janus Henderson Group PLC - MarketBeat
(HRMY) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Why Harmony Biosciences (HRMY) Is Up 9.0% After Q2 Earnings Surge And Pipeline Progress - Sahm
Harmony Profit Jumps as WAKIX Revenue Climbs 30% - MyChesCo
Harmony Biosciences (NASDAQ:HRMY) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Harmony Biosciences (HRMY) Is Up 9.0% After Q2 Earnings Jump And Pipeline ProgressWhat's Changed - Yahoo Finance
Harmony Biosciences (NASDAQ: HRMY) holder to sell 700,883 shares - Stock Titan
Harmony Biosciences Holdings, Inc. Just Recorded A 34% EPS Beat: Here's What Analysts Are Forecasting Next - Moomoo
First Trust Advisors LP Sells 50,805 Shares of Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences Holdings Inc (HRMY) Stock News Today - TradingKey
Harmony Biosciences Holdings Inc (HRMY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Harmony Biosciences to Participate in Piper Sandler Virtual CNS Symposium - The Manila Times
Harmony Biosciences management plans Aug. 13 fireside chat webcast - Stock Titan
Harmony Biosciences: Management Raised Its Game, But The Stock Has Already Rerated (HRMY) - Seeking Alpha
HRMY Q2 Earnings Beat Estimates on Strong Wakix Sales, Stock Up - Yahoo Finance
Analysts Are Bullish on These Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Beam Therapeutics (BEAM) - The Globe and Mail
Here is Why Growth Investors Should Buy Harmony Biosciences (HRMY) Now - Yahoo Finance
Deutsche Bank Adjusts Harmony Biosciences Price Target to $39 From $36, Maintains Hold Rating - marketscreener.com
Harmony Biosciences Says New Data Supports Neurology Pipeline - benzinga.com
Harmony Biosciences Holdings, Inc. $HRMY Stock Holdings Lifted by Pacer Advisors Inc. - MarketBeat
Harmony Biosciences Q2 2026 slides: record WAKIX quarter, BP-205 data - Investing.com
Sei Investments Co. Has $5.44 Million Position in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences Q2 2026 earnings: WAKIX revenue rises 30% - TradingKey
Harmony Biosciences Holdings Inc (HRMY) (Q2 2026) Earnings Call - GuruFocus
Harmony Biosciences Holdings, Inc. Stock 12‑Month Price Target Cut to $44.7, Implies 26% Upside - TradingView
Harmony Biosciences Holdings, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Harmony Biosciences Holdings, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:HRMY) 2026-08-04 - Seeking Alpha
Harmony Biosciences Holdings Inc (HRMY) (Q2 2026) Earnings Call Highlights: Record Revenue and ... - Yahoo Finance UK
Harmony Biosciences Holdings Surges 11.0% Amid Sector-Wide Rally - AlphaStreet
Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $70 at Oppenheimer - StreetInsider
Oppenheimer lowers Harmony Biosciences stock price target on model updates - Investing.com
Needham & Company LLC Forecasts Strong Price Appreciation for Harmony Biosciences (NASDAQ:HRMY) Stock - MarketBeat
Is Harmony Biosciences (HRMY) Undervalued After Q2 Earnings? EPS - GuruFocus
Harmony Biosciences Holdings Inc (HRMY) 財務データ
収益
当期純利益
現金流量
EPS
0.00%
3.22%
大文字化:
|
ボリューム (24 時間):